Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Crit Rev Oncol Hematol. 2024 May 28:104401. doi: 10.1016/j.critrevonc.2024.104401. Online ahead of print.
ABSTRACT
Several observations indicate that protein expression analysis by immunohistochemistry (IHC) remains relevant in individuals with non-small-cell lung cancer (NSCLC) when considering targeted therapy, as an early step in diagnosis and for therapy selection. Since the advent of next-generation sequencing (NGS), the role of IHC in testing for NSCLC biomarkers has been forgotten or ignored. We discuss how protein-level investigations maintain a critical role in defining sensitivity to lung cancer therapies in oncogene- and non-oncogene-addicted cases and in patients eligible for immunotherapy, suggesting that IHC testing should be reconsidered in clinical practice. We also argue how a panel of IHC tests should be considered complementary to NGS and other genomic assays. This is relevant to current clinical diagnostic practice but with potential future roles to optimize the selection of patients for innovative therapies. At the same time, strict validation of antibodies, assays, scoring systems, and intra- and interobserver reproducibility is needed.
PMID:38815876 | DOI:10.1016/j.critrevonc.2024.104401
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Rediscovering immunohistochemistry in lung cancer
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review) EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape Critical role of the gut microbiota in immune responses and cancer immunotherapy Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1 A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Metastasis of Non-small Cell Lung Cancer Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT CUNet3+: A Multi-scale Connected UNet for the Segmentation of Lung Cancer Cells in Pathology Sections Stained using Rapid On-Site Cytopathological Evaluation Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer Genetic correlation and causal associations between psychiatric disorders and lung cancer risk ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway Patterns of brain metastases response to immunotherapy with pembrolizumab Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer? Immune cell infiltration and inflammatory landscape in primary brain tumours Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2 Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade HER2-low breast cancer: insights on pathological testing Systematic review and meta-analysis of deep learning applications in computed tomography lung cancer segmentation An Extensive Review on Lung Cancer Therapeutics Using Machine Learning Techniques: State-of-the-art and Perspectives Integrated analysis of the role of PR/SET domain 14 in gastric cancer Integrated analysis of the role of PR/SET domain 14 in gastric cancer Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer Dissecting the MUC5AC/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma Artificial Intelligence: Can It Save Lives, Hospitals and Lung Screening? Impact of PD-L1 Expression on the Overall Survival of Caucasian Patients with Advanced EGFR-Mutant NSCLC Treated with Frontline Osimertinib Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediators Quantitative analysis of interstitial lung abnormalities on computed tomography to predict symptomatic radiation pneumonitis after lung stereotactic body radiotherapy Perioperative imaging predictors of tumor progression and pseudoprogression: a systematic review Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families from the Lynch Memorial Biobank reveals complex genetic architecture and phenocopies Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours The mediating role of health behaviors in the association between depression, anxiety and cancer incidence: an individual participant data meta-analysis Comparison of lung ultrasound assisted by artificial intelligence to radiology examination in pneumothorax Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology Bronchiectatic Actinomycosis with Osseous Metaplasia Masquerading as Lung Cancer Bronchiectatic Actinomycosis with Osseous Metaplasia Masquerading as Lung Cancer Artificial intelligence's contribution to early pulmonary lesion detection in chest X-rays: insights from two retrospective studies on a Czech population Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer Appendix removal affects the subsequent cancer risk in Asian adults: a territory-wide population-based cohort study Cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study
Evidence Blueprint
Rediscovering immunohistochemistry in lung cancer
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Rediscovering immunohistochemistry in lung cancer
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: a report from an expert panel of Italian medical and radiation oncologists - INTERACTION GROUP Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience Lung cancer oncogene-directed therapy, fertility and pregnancy Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review) EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings Recent advances in lung cancer research: unravelling the future of treatment A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape Critical role of the gut microbiota in immune responses and cancer immunotherapy Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach? Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1 A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis New funding for development of world's first lung cancer vaccine Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p Racial/Ethnic disparities in exposure to neighborhood violence and lung cancer risk in Chicago Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Metastasis of Non-small Cell Lung Cancer Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT CUNet3+: A Multi-scale Connected UNet for the Segmentation of Lung Cancer Cells in Pathology Sections Stained using Rapid On-Site Cytopathological Evaluation Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer Brain metastasis screening in the molecular age Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L858R compound EGFR mutations: a case report Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it? Music therapy, quality of life and efficacy of immunotherapy for NSCLC The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape Genetic correlation and causal associations between psychiatric disorders and lung cancer risk Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma Effects of autolysis and prolonged formalin fixation on histomorphology and immunohistochemistry of normal canine brain tissue: an experimental study Nicotinic acetylcholine receptors in cancer: Limitations and prospects Associating CYP2A6 structural variants with ovarian and lung cancer risk in the UK Biobank: replication and extension ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway Patterns of brain metastases response to immunotherapy with pembrolizumab Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer? Prognostic and immune roles of UROC1 in human cancers: from mechanism exploration of NAFLD and HCC to pan-cancer analysis Immune cell infiltration and inflammatory landscape in primary brain tumours Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2 Real-world analysis of the relationships between smoking, lung cancer stigma, and emotional functioning